Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ability of the Probiotic VE818 to Reduce Enteropathogen Colonization and Improve Environmental Enteropathy in Pregnant Women: A Proof-of-Concept and Phase II Randomized Placebo-Controlled Trial in Bangladesh, Pakistan, Zambia, and Burkina Faso

NCT06817031 is registered in ClinicalTrials.gov with International Centre for Diarrhoeal Disease Research, Bangladesh as lead sponsor.

NCT NCT06817031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06817031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ability of the Probiotic VE818 to Reduce Enteropathogen Colonization and Improve Environmental Enteropathy in Pregnant Women: A Proof-of-Concept and Phase II Randomized Placebo-Controlled Trial in Bangladesh, Pakistan, Zambia, and Burkina Faso
Lead sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
April 20, 2025
Completion date
October 31, 2026
Enrollment
144 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

environmental enteric dysfunction